Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DT2B6G
|
|||
| Drug Name |
SER-401
|
|||
| Drug Type |
Live biotherapeutic product
|
|||
| Indication | Metastatic melanoma [ICD-11: 2E2Z; ICD-10: C76-C80] | Phase 1 | [1] | |
| Company |
Seres Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03817125) Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention (MCGRAW). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.